Through this approach, we demonstrate the capability to not only sensitively detect deficiencies in insulin-stimulated exogenous glucose disposal but also identify subtle impairments in insulin-induced EGP suppression even without the presence of hyperinsulinemia. The gene discussed is INS; the disease is Hyperinsulinemia.